Search research articles
Contact Us
Filters
Showing results (81-90 of 116) with videos related to
Page
of 12
Sort By:
The Journal of Investigative Dermatology
|
April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort
Gregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
Molecular Oncology
|
October 7, 2015
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
Gregory A Chang, Jyothirmayee S Tadepalli, Yongzhao Shao, et al.
Oncology
|
June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survival
Ting J Tu, Michelle W Ma, Stefano Monni, et al.
Journal of Translational Medicine
|
November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survival
Justin Rendleman, Shulian Shang, Christine Dominianni, et al.
Plos One
|
January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlates
Patrick A Ott, Anne Hamilton, Christina Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma
David B Solit, Iman Osman, David Polsky, et al.
Archives of Dermatology
|
April 23, 2008
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma
Naheed R Abbasi, Molly Yancovitz, Dina Gutkowicz-Krusin, et al.
Life Science Alliance
|
July 26, 2023
Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice
Naomi I Maria, Julien Papoin, Chirag Raparia, et al.
Oncology
|
June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care
Chloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients
Bruce Ng, Jan Zakrzewski, Melanie Warycha, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 116) with videos related to
Sort By:
Page
of 12
The Journal of Investigative Dermatology
|
April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort
Gregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
Molecular Oncology
|
October 7, 2015
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
Gregory A Chang, Jyothirmayee S Tadepalli, Yongzhao Shao, et al.
Oncology
|
June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survival
Ting J Tu, Michelle W Ma, Stefano Monni, et al.
Journal of Translational Medicine
|
November 6, 2013
Melanoma risk loci as determinants of melanoma recurrence and survival
Justin Rendleman, Shulian Shang, Christine Dominianni, et al.
Plos One
|
January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlates
Patrick A Ott, Anne Hamilton, Christina Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2008
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma
David B Solit, Iman Osman, David Polsky, et al.
Archives of Dermatology
|
April 23, 2008
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma
Naheed R Abbasi, Molly Yancovitz, Dina Gutkowicz-Krusin, et al.
Life Science Alliance
|
July 26, 2023
Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice
Naomi I Maria, Julien Papoin, Chirag Raparia, et al.
Oncology
|
June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care
Chloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2008
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients
Bruce Ng, Jan Zakrzewski, Melanie Warycha, et al.
Page
of 12